Cargando…
SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity
Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyt...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205251/ https://www.ncbi.nlm.nih.gov/pubmed/34171266 http://dx.doi.org/10.1016/j.chom.2021.06.006 |
_version_ | 1783708470694903808 |
---|---|
author | Motozono, Chihiro Toyoda, Mako Zahradnik, Jiri Saito, Akatsuki Nasser, Hesham Tan, Toong Seng Ngare, Isaac Kimura, Izumi Uriu, Keiya Kosugi, Yusuke Yue, Yuan Shimizu, Ryo Ito, Jumpei Torii, Shiho Yonekawa, Akiko Shimono, Nobuyuki Nagasaki, Yoji Minami, Rumi Toya, Takashi Sekiya, Noritaka Fukuhara, Takasuke Matsuura, Yoshiharu Schreiber, Gideon Ikeda, Terumasa Nakagawa, So Ueno, Takamasa Sato, Kei |
author_facet | Motozono, Chihiro Toyoda, Mako Zahradnik, Jiri Saito, Akatsuki Nasser, Hesham Tan, Toong Seng Ngare, Isaac Kimura, Izumi Uriu, Keiya Kosugi, Yusuke Yue, Yuan Shimizu, Ryo Ito, Jumpei Torii, Shiho Yonekawa, Akiko Shimono, Nobuyuki Nagasaki, Yoji Minami, Rumi Toya, Takashi Sekiya, Noritaka Fukuhara, Takasuke Matsuura, Yoshiharu Schreiber, Gideon Ikeda, Terumasa Nakagawa, So Ueno, Takamasa Sato, Kei |
author_sort | Motozono, Chihiro |
collection | PubMed |
description | Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R (in B.1.427/429 and B.1.617) and Y453F (in B.1.1.298), confer escape from HLA-A24-restricted cellular immunity. These mutations reinforce affinity toward the host entry receptor ACE2. Notably, the L452R mutation increases spike stability, viral infectivity, viral fusogenicity, and thereby promotes viral replication. These data suggest that HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes and that a further threat of the SARS-CoV-2 pandemic is escape from cellular immunity. |
format | Online Article Text |
id | pubmed-8205251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Authors. Published by Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82052512021-06-16 SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity Motozono, Chihiro Toyoda, Mako Zahradnik, Jiri Saito, Akatsuki Nasser, Hesham Tan, Toong Seng Ngare, Isaac Kimura, Izumi Uriu, Keiya Kosugi, Yusuke Yue, Yuan Shimizu, Ryo Ito, Jumpei Torii, Shiho Yonekawa, Akiko Shimono, Nobuyuki Nagasaki, Yoji Minami, Rumi Toya, Takashi Sekiya, Noritaka Fukuhara, Takasuke Matsuura, Yoshiharu Schreiber, Gideon Ikeda, Terumasa Nakagawa, So Ueno, Takamasa Sato, Kei Cell Host Microbe Short Article Many SARS-CoV-2 variants with naturally acquired mutations have emerged. These mutations can affect viral properties such as infectivity and immune resistance. Although the sensitivity of naturally occurring SARS-CoV-2 variants to humoral immunity has been investigated, sensitivity to human leukocyte antigen (HLA)-restricted cellular immunity remains largely unexplored. Here, we demonstrate that two recently emerging mutations in the receptor-binding domain of the SARS-CoV-2 spike protein, L452R (in B.1.427/429 and B.1.617) and Y453F (in B.1.1.298), confer escape from HLA-A24-restricted cellular immunity. These mutations reinforce affinity toward the host entry receptor ACE2. Notably, the L452R mutation increases spike stability, viral infectivity, viral fusogenicity, and thereby promotes viral replication. These data suggest that HLA-restricted cellular immunity potentially affects the evolution of viral phenotypes and that a further threat of the SARS-CoV-2 pandemic is escape from cellular immunity. The Authors. Published by Elsevier Inc. 2021-07-14 2021-06-15 /pmc/articles/PMC8205251/ /pubmed/34171266 http://dx.doi.org/10.1016/j.chom.2021.06.006 Text en © 2021 The Authors Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Article Motozono, Chihiro Toyoda, Mako Zahradnik, Jiri Saito, Akatsuki Nasser, Hesham Tan, Toong Seng Ngare, Isaac Kimura, Izumi Uriu, Keiya Kosugi, Yusuke Yue, Yuan Shimizu, Ryo Ito, Jumpei Torii, Shiho Yonekawa, Akiko Shimono, Nobuyuki Nagasaki, Yoji Minami, Rumi Toya, Takashi Sekiya, Noritaka Fukuhara, Takasuke Matsuura, Yoshiharu Schreiber, Gideon Ikeda, Terumasa Nakagawa, So Ueno, Takamasa Sato, Kei SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
title | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
title_full | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
title_fullStr | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
title_full_unstemmed | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
title_short | SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity |
title_sort | sars-cov-2 spike l452r variant evades cellular immunity and increases infectivity |
topic | Short Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205251/ https://www.ncbi.nlm.nih.gov/pubmed/34171266 http://dx.doi.org/10.1016/j.chom.2021.06.006 |
work_keys_str_mv | AT motozonochihiro sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT toyodamako sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT zahradnikjiri sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT saitoakatsuki sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT nasserhesham sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT tantoongseng sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT ngareisaac sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT kimuraizumi sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT uriukeiya sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT kosugiyusuke sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT yueyuan sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT shimizuryo sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT itojumpei sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT toriishiho sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT yonekawaakiko sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT shimononobuyuki sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT nagasakiyoji sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT minamirumi sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT toyatakashi sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT sekiyanoritaka sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT fukuharatakasuke sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT matsuurayoshiharu sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT schreibergideon sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT ikedaterumasa sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT nakagawaso sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT uenotakamasa sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity AT satokei sarscov2spikel452rvariantevadescellularimmunityandincreasesinfectivity |